KHOS-312H Cells

KHOS-312H is a human osteosarcoma cell line derived from bone cancer. This cell line is part of a group of KHOS-derived osteosarcoma models, which includes KHOSNP and KHOS-240S, among others. Like other osteosarcoma cell lines, KHOS-312H is used extensively in cancer research to study the biology of osteosarcomas, particularly their genetic and molecular characteristics, and to evaluate potential therapeutic agents. The KHOS-312H cell line is known for its resistance to certain targeted kinase inhibitors, such as those affecting the PI3K-Akt-mTOR pathway, making it an essential model for studying drug resistance mechanisms in osteosarcoma.

One of the significant features of the KHOS-312H cell line is its utility in high-throughput screening for anticancer drugs. In large-scale screening studies, KHOS-312H has been tested against a wide array of compounds, including both FDA-approved drugs and investigational agents. These studies have revealed that KHOS-312H shows varying degrees of sensitivity and resistance to different classes of anticancer drugs, helping researchers to map the molecular landscape of osteosarcoma response to treatment. Notably, the cell line’s resistance to mTOR inhibitors has been particularly highlighted, suggesting a potential need for combination therapies or novel agents to overcome this challenge.